The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Contrasting Genetic Influence of CCR2 and CCR5 Variants on HIV-1 Infection and Disease Progression
Abstract
The critical role of chemokine receptors (CCR5 and CXCR4) in human immunodeficiency virus–type 1 (HIV-1) infection and pathogenesis prompted a search for polymorphisms in other chemokine receptor genes that mediate HIV-1 disease progression. A mutation ( CCR2-64I ) within the first transmembrane region of the CCR2 chemokine and HIV-1 receptor gene is described that occurred at an allele frequency of 10 to 15 percent among Caucasians and African Americans. Genetic association analysis of five acquired immunodeficiency syndrome (AIDS) cohorts (3003 patients) revealed that although CCR2-64I exerts no influence on the incidence of HIV-1 infection, HIV-1–infected individuals carrying the CCR2 - 64I allele progressed to AIDS 2 to 4 years later than individuals homozygous for the common allele. Because CCR2-64I occurs invariably on a CCR5-+ –bearing chromosomal haplotype, the independent effects of CCR5-Δ32 (which also delays AIDS onset) and CCR2-64I were determined. An estimated 38 to 45 percent of AIDS patients whose disease progresses rapidly (less than 3 years until onset of AIDS symptoms after HIV-1 exposure) can be attributed to their CCR2-+/+ or CCR5-+/+ genotype, whereas the survival of 28 to 29 percent of long-term survivors, who avoid AIDS for 16 years or more, can be explained by a mutant genotype for CCR2 or CCR5.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor
Feng, Y., Broder, C. C., Kennedy, P. E., & Berger, E. A. (1996) · Science · doi:10.1126/science.272.5263.872 · Cited by 4,172
Identification of a major co-receptor for primary isolates of HIV-1
Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Marzio, P. D., Marmon, S., Sutton, R. E., Hill, C. M., et al. (1996) · Nature · doi:10.1038/381661a0 · Cited by 3,641
Liu, R., Paxton, W. A., Choe, S., Ceradini, D., Martin, S. R., Horuk, R., MacDonald, M. E., Stuhlmann, H., Koup, R. A., & Landau, N. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80110-5 · Cited by 3,074
Samson, M., Libert, F., Doranz, B. J., Rucker, J., Liesnard, C., Farber, C.-M., Saragosti, S., Lapouméroulie, C., Cognaux, J., Forceille, C., et al. (1996) · Nature · doi:10.1038/382722a0 · Cited by 2,886
Cocchi, F., DeVico, A. L., Garzino-Demo, A., Arya, S. K., Gallo, R. C., & Lusso, P. (1995) · Science · doi:10.1126/science.270.5243.1811 · Cited by 2,869
Dean, M., Carrington, M., Winkler, C., Huttley, G. A., Smith, M. W., Allikmets, R., Goedert, J. J., Buchbinder, S. P., Vittinghoff, E., Gomperts, E., et al. (1996) · Science · doi:10.1126/science.273.5283.1856 · Cited by 2,484
Self-citationThe β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates
Choe, H., Farzan, M., Sun, Y., Sullivan, N., Rollins, B., Ponath, P. D., Wu, L., Mackay, C. R., LaRosa, G., Newman, W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81313-6 · Cited by 2,287
The role of a mutant CCR5 allele in HIV–1 transmission and disease progression
Huang, Y., Paxton, W. A., Wolinsky, S. M., Neumann, A. U., Zhang, L., He, T., Kang, S., Ceradini, D., Jin, Z., Yazdanbakhsh, K., et al. (1996) · Nature Medicine · doi:10.1038/nm1196-1240 · Cited by 1,358
Genotypic and Phenotypic Characterization of HIV-1 Patients with Primary Infection
Zhu, T., Mo, H., Wang, N., Nam, D. S., Cao, Y., Koup, R. A., & Ho, D. D. (1993) · Science · doi:10.1126/science.8356453 · Cited by 1,249
KASLOW, R. A., OSTROW, D. G., DETELS, R., PHAIR, J. P., POLK, B. F., RINALDO, C. R., & STUDY, F. T. M. A. C. (1987) · American Journal of Epidemiology · doi:10.1093/aje/126.2.310 · Cited by 1,194
Self-citation
Cited by
Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease
Berger, E. A., Murphy, P. M., & Farber, J. M. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.657 · Cited by 2,180
International Union of Pharmacology. XXII. Nomenclature for Chemokine Receptors
Murphy, P. M., Baggiolini, M., Charo, I. F., Hébert, C. A., Horuk, R., Matsushima, K., Miller, L. H., Oppenheim, J. J., & Power, C. A. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01439-x · Cited by 1,817
Gene–environment interactions in psychiatry: joining forces with neuroscience
Caspi, A., & Moffitt, T. E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1925 · Cited by 1,300
The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation
Study, T. I. H. C. (2010) · Science · doi:10.1126/science.1195271 · Cited by 1,171
Gene–environment interactions in human diseases
Hunter, D. J. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1578 · Cited by 1,132
Migueles, S. A., Sabbaghian, M. S., Shupert, W. L., Bettinotti, M. P., Marincola, F. M., Martino, L., Hallahan, C. W., Selig, S. M., Schwartz, D., Sullivan, J., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050567397 · Cited by 995
Chemokines in the Pathogenesis of Vascular Disease
Charo, I. F., & Taubman, M. B. (2004) · Circulation Research · doi:10.1161/01.res.0000146672.10582.17 · Cited by 752
Acute Human Immunodeficiency Virus Type 1 Infection
Kahn, J. O., & Walker, B. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807023390107 · Cited by 733
Kuziel, W. A., Morgan, S. J., Dawson, T. C., Griffin, S., Smithies, O., Ley, K., & Maeda, N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.22.12053 · Cited by 709
Cooper, D. N., Krawczak, M., Polychronakos, C., Tyler-Smith, C., & Kehrer-Sawatzki, H. (2013) · Human Genetics · doi:10.1007/s00439-013-1331-2 · Cited by 645
Population genetics—making sense out of sequence
Chakravarti, A. (1999) · Nature Genetics · doi:10.1038/4482 · Cited by 628
THE IMMUNOGENETICS OF HUMAN INFECTIOUS DISEASES
Hill, A. V. S. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.593 · Cited by 581
Dating the Origin of the CCR5-Δ32 AIDS-Resistance Allele by the Coalescence of Haplotypes
Stephens, J. C., Reich, D. E., Goldstein, D. B., Shin, H. D., Smith, M. W., Carrington, M., Winkler, C., Huttley, G. A., Allikmets, R., Schriml, L., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301867 · Cited by 520
“%) missense-mutation allele (64I) of the CCR2 locus 18 kb from CCR5 is also in complete linkage disequilibrium with CCR5-ϩ (Smith et al. 1997).”
BackgroundSelf-citationCartier, L., Hartley, O., Dubois-Dauphin, M., & Krause, K.-H. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.07.021 · Cited by 509
Human genetic susceptibility to infectious disease
Chapman, S. J., & Hill, A. V. S. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3114 · Cited by 499
Cook, D. N., Prosser, D. M., Forster, R., Zhang, J., Kuklin, N. A., Abbondanzo, S. J., Niu, X.-D., Chen, S.-C., Manfra, D. J., Wiekowski, M. T., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)80201-0 · Cited by 498
Effect of a Single Amino Acid Change in MHC Class I Molecules on the Rate of Progression to AIDS
Gao, X., Nelson, G. W., Karacki, P., Martin, M. P., Phair, J., Kaslow, R., Goedert, J. J., Buchbinder, S., Hoots, K., Vlahov, D., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442203 · Cited by 487
Self-citationPharmacogenetics, Pharmacogenomics, and Individualized Medicine
Ma, Q., & Lu, A. Y. H. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003533 · Cited by 464
Genetic Acceleration of AIDS Progression by a Promoter Variant of CCR5
Martin, M. P. (1998) · Science · doi:10.1126/science.282.5395.1907 · Cited by 461
Alter, G., Martin, M. P., Teigen, N., Carr, W. H., Suscovich, T. J., Schneidewind, A., Streeck, H., Waring, M., Meier, A., Brander, C., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070695 · Cited by 455
Self-citationGenetics of susceptibitlity to human infectious disease
Cooke, G. S., & Hill, A. V. S. (2001) · Nature Reviews Genetics · doi:10.1038/35103577 · Cited by 444
Common Genetic Variation and the Control of HIV-1 in Humans
Fellay, J., Ge, D., Shianna, K. V., Colombo, S., Ledergerber, B., Cirulli, E. T., Urban, T. J., Zhang, K., Gumbs, C. E., Smith, J. P., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000791 · Cited by 419
Self-citationImmunology and Evolution of Infectious Disease
Frank, S. A. (2002) · Princeton University Press eBooks · doi:10.1515/9780691220161 · Cited by 393
CCR5 promoter polymorphism and HIV-1 disease progression
McDermott, D. H., Zimmerman, P. A., Guignard, F., Kleeberger, C. A., Leitman, S. F., & Murphy, P. M. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04158-0 · Cited by 390
Mellado, M., Rodríguez-Frade, J. M., Mañes, S., & Martínez-A, C. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.397 · Cited by 390
Kostrikis, L. G., Huang, Y., Moore, J. P., Wolinsky, S. M., Zhang, L., Guo, Y., Deutsch, L., Phair, J., U. Neumann, A., & D. Ho, D. (1998) · Nature Medicine · doi:10.1038/nm0398-350 · Cited by 388
Patterns of Human Genetic Diversity: Implications for Human Evolutionary History and Disease
Tishkoff, S. A., & Verrelli, B. C. (2003) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.4.070802.110226 · Cited by 388
Mechanism of Transdominant Inhibition of CCR5-mediated HIV-1 Infection by ccr5Δ32
Benkirane, M., Jin, D.-Y., Chun, R. F., Koup, R. A., & Jeang, K.-T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.30603 · Cited by 377
Heterodimerization of G Protein-Coupled Receptors: Specificity and Functional Significance
Prinster, S. C., Hague, C., & Hall, R. A. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.3.1 · Cited by 374
Horuk, R. (2001) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00014-4 · Cited by 344
Mummidi, S., Ahuja, S. S., Gonalez, E., Anderson, S. A., Santiago, E. N., Stephan, K. T., Craig, F. E., O'Connell, P., Tryon, V., Clark, R. A., et al. (1998) · Nature Medicine · doi:10.1038/nm0798-786 · Cited by 339
Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression
Liu, H., Chao, D., Nakayama, E. E., Taguchi, H., Goto, M., Xin, X., Takamatsu, J.-K., Saito, H., Ishikawa, Y., Akaza, T., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4581 · Cited by 332
Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis
Peters, W., Scott, H. M., Chambers, H. F., Flynn, J. L., Charo, I. F., & Ernst, J. D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131207398 · Cited by 331
Chemokines in asthma: Cooperative interaction between chemokines and IL-13
Rosenwasser, L. J., Zimmermann, N., Hershey, G. K., Foster, P. S., & Rothenberg, M. E. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.139 · Cited by 331
Learmont, J. C., Geczy, A. F., Mills, J., Ashton, L. J., Raynes-Greenow, C. H., Garsia, R. J., Dyer, W. B., McIntyre, L., Oelrichs, R. B., Rhodes, D. I., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906033402203 · Cited by 329
O'Brien, S. J., & Nelson, G. W. (2004) · Nature Genetics · doi:10.1038/ng1369 · Cited by 319
Self-citationSzalai, C., Duba, J., Prohászka, Z., Kalina, Á., Szabó, T., Nagy, B., Horváth, L., & Császár, A. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00423-3 · Cited by 317
Spectral Genotyping of Human Alleles
Kostrikis, L. G., Tyagi, S., Mhlanga, M. M., Ho, D. D., & Kramer, F. R. (1998) · Science · doi:10.1126/science.279.5354.1228 · Cited by 315
Ioannidis, J. P. A., Rosenberg, P. S., Goedert, J. J., Ashton, L. J., Benfield, T. L., Buchbinder, S. P., Coutinho, R. A., Eugen-Olsen, J., Gallart, T., Katzenstein, T. L., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-9-200111060-00008 · Cited by 300
Self-citationMolecular, Endocrine, and Genetic Mechanisms of Arterial Calcification
Doherty, T. M., Fitzpatrick, L. A., Inoue, D., Qiao, J.-H., Fishbein, M. C., Detrano, R. C., Shah, P. K., & Rajavashisth, T. B. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0015 · Cited by 299
New Class I and II HLA Alleles Strongly Associated with Opposite Patterns of Progression to AIDS
Hendel, H., Caillat-Zucman, S., Lebuanec, H., Carrington, M., O’Brien, S., Andrieu, J.-M., Schächter, F., Zagury, D., Rappaport, J., Winkler, C., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.11.6942 · Cited by 296
Self-citationWhite, G. E., Iqbal, A. J., & Greaves, D. R. (2013) · Pharmacological Reviews · doi:10.1124/pr.111.005074 · Cited by 289
Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10
Shin, H. D., Winkler, C., Stephens, J. C., Bream, J., Young, H., Goedert, J. J., O'Brien, T. R., Vlahov, D., Buchbinder, S., Giorgi, J., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.26.14467 · Cited by 286
Self-citationHLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C
Thomas, R., Apps, R., Qi, Y., Gao, X., Male, V., O'hUigin, C., O'Connor, G., Ge, D., Fellay, J., Martin, J. N., et al. (2009) · Nature Genetics · doi:10.1038/ng.486 · Cited by 283
Self-citationChemokines and Chemokine Receptors: Biology and Clinical Relevance in Inflammation and AIDS
Locati, M., & Murphy, M. (1999) · Annual Review of Medicine · doi:10.1146/annurev.med.50.1.425 · Cited by 283
McDermott, D. H., Fong, A. M., Yang, Q., Sechler, J. M., Cupples, L. A., Merrell, M. N., Wilson, P. W. F., D’Agostino, R. B., O’Donnell, C. J., Patel, D. D., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16790 · Cited by 281
Evidence for a newly discovered cellular anti-HIV-1 phenotype
Simon, J. H. M., Gaddis, N. C., Fouchier, R. A. M., & Malim, M. H. (1998) · Nature Medicine · doi:10.1038/3987 · Cited by 280
HIV-1 Tat protein mimicry of chemokines
Albini, A., Ferrini, S., Benelli, R., Sforzini, S., Giunciuglio, D., Aluigi, M. G., Proudfoot, A. E. I., Alouani, S., Wells, T. N. C., Mariani, G., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13153 · Cited by 279
Mechanisms of Regulation of the Chemokine-Receptor Network
Stone, M., Hayward, J., Huang, C., E. Huma, Z., & Sanchez, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020342 · Cited by 275
HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene
Quillent, C., Oberlin, E., Braun, J., Rousset, D., Gonzalez-Canali, G., Métais, P., Montagnier, L., Virelizier, J.-L., Arenzana-Seisdedos, F., & Beretta, A. (1998) · The Lancet · doi:10.1016/s0140-6736(97)09185-x · Cited by 271
MacDonald, K. S., Fowke, K. R., Kimani, J., Dunand, V. A., Nagelkerke, N. J. D., Ball, T. B., Oyugi, J., Njagi, E., Gaur, L. K., Brunham, R. C., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315472 · Cited by 269
The Genomics and Genetics of Human Infectious Disease Susceptibility
Hill, A. V. S. (2001) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.2.1.373 · Cited by 264
Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity
Flores-Villanueva, P. O., Yunis, E. J., Delgado, J. C., Vittinghoff, E., Buchbinder, S., Leung, J. Y., Uglialoro, A. M., Clavijo, O. P., Rosenberg, E. S., Kalams, S. A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.071548198 · Cited by 263
Self-citationEfficacy at g-protein-coupled receptors
Kenakin, T. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd722 · Cited by 263
CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis
Zhang, J., Patel, L., & Pienta, K. J. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.11.009 · Cited by 261
Percherancier, Y., Berchiche, Y. A., Slight, I., Volkmer-Engert, R., Tamamura, H., Fujii, N., Bouvier, M., & Heveker, N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411151200 · Cited by 261
Cell surface receptors, virus entry and tropism of primate lentiviruses
Clapham, P. R., & McKnight, Á. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-8-1809 · Cited by 256
Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes
Gonzalez, E., Bamshad, M., Sato, N., Mummidi, S., Dhanda, R., Catano, G., Cabrera, S., McBride, M., Cao, X.-H., Merrill, G., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.12004 · Cited by 253
Lim, J. K., Obara, C. J., Rivollier, A., Pletnev, A. G., Kelsall, B. L., & Murphy, P. M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003003 · Cited by 176
Metadata
- Authors
- Smith, M. W., Dean, M., Carrington, M., Winkler, C., Huttley, G. A., Lomb, D. A., Goedert, J. J., O'Brien, T. R., Jacobson, L. P., Kaslow, R., Buchbinder, S., Vittinghoff, E., Vlahov, D., Hoots, K., Hilgartner, M. W., (HGDS), H. G. A. D. S., Study, M. A. C. S. (., & O'Brien, S. J.
- Venue
- Science
- Published
- 1997-08-15
- Volume
- 277
- Issue
- 5328
- Pages
- 959-965
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2149730509
- Cited by
- 876
- References
- 38
- FWCI
- 24.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.